• Network Genomic Medicine
  • CIO Cologne Bonn
  • Contact
  • Imprint
  • Privacy Policy
  • English
    • Deutsch
Lung Cancer Group Cologne
  • Who we are
    • Aims
    • Study coordination
    • Team
  • Publications
    • Publications
    • Projects
  • Molecularpathology
    • For patients
    • Molecular Testing
    • Translational Genomics
  • Cologne Conference on Lung Cancer
  • Overview
  • Immunotherapy Trials
Select Page

PD-L1 expression in small cell neuroendocrine carcinomas.

Schultheis AM, Scheel AH, Ozretić L, George J, Thomas RK, Hagemann T, Zander T, Wolf J, Buettner R.

Journal: Eur J Cancer
Veröffentlichung: 9. Jan. 2015

The LCGC study center team, led by prof. Juergen Wolf, is located at Dept. I of Internal Medicine in the Center for Integrated Oncology at the University Hospital Cologne. Our goal is to achieve an effective treatment for patients with lung cancer.
For this purpose we are developing our own study reports for treating genetically defined subgroups of lung cancer and to optimize immunotherapy. We do this in close cooperation with the work groups in translational cancer genomics, molecular pathology and molecular imaging.

„NGMCIO Köln BonnUniklinik Köln

Ansprechpartner & Kontaktdaten

Universitätsklinik Köln (AöR)
Klinik I für Innere Medizin

Lung Cancer Group Cologne (LCGC)
am Centrum für Integrierte Onkologie Köln Bonn

Kerpener Str. 62 | 50937 Köln

Tel.: 0221 478 87008

Fax: 0221 478 87010
E-Mail: lungenkrebs@uk-koeln.de

… mehr erfahren Sie hier!

  • © 2015 LungCancerGroupCologne
  • Sitemap
  • Contact
  • Imprint
  • Terms & Conditions
  • Privacy Policy

Designed by Elegant Themes | Powered by WordPress